MigVax is developing an oral subunit vaccine for COVID-19. MigVax team has combined decades of track record with successful global vaccine and pharmaceutical achievements. Requirement: • Proficiency in Quality Assurance aspects of biological drug development o Knowledge of GMP-based requirements o Training of R&D teams in QA aspects, follow up on daily documentation and work performance o Design and establishment of a Controlled Documents Bank o Support writing of SOPs, working instructions, protocols etc for all experimental work; design of forms for experiment documentation o Design of qualification and validation of assays in collaboration with R&D team, support performance and report writing o Definition of QA requirements for equipment, follow up on calibration and maintenance o Good insights into Quality Control requirements for Biologics • Good understanding in Protein Biochemistry o Protein expression in different expression systems o Protein purification – SEC, Inversed Phase, affinity (Akta) o Protein analysis: ELISA, WB, impurities (HPLC) o Chemical analysis o Protein activity analysis: In vitro and cell-based assays